<DOC>
	<DOCNO>NCT00661635</DOCNO>
	<brief_summary>To evaluate analgesic efficacy , general safety , effect health outcome measure opioid-related symptom 2 valdecoxib dose regimen compare placebo patient moderate severe pain follow laparoscopic cholecystectomy surgery .</brief_summary>
	<brief_title>A Randomized , Double-Blind Study Efficacy Safety Valdecoxib Compared Placebo Treatment Post- Cholecystectomy Surgery Pain</brief_title>
	<detailed_description />
	<mesh_term>Valdecoxib</mesh_term>
	<criteria>Patients require elective , nonurgent laparoscopic cholecystectomy , outpatient procedure , ASA Class IIII , Baseline Pain Intensity moderate severe categorical scale â‰¥45 mm VAS ( 100 mm ) Patients able get first dose study medication within 8 hour end surgery Patients could undergo procedure expect produce great degree surgical trauma laparoscopic cholecystectomy alone , acute preoperative pain ( biliary colic ) chronic pain condition , uncontrolled chronic condition , cancer , laboratory abnormality investigator consider contraindicate study participation Patient cognitive impairment would , investigator 's opinion , preclude study participation compliance protocol mandate procedure Patient history know alcohol , analgesic , narcotic substance abuse within one year prior Screening Patient laboratory abnormality screening , , opinion investigator , due condition require surgery expect resolve postsurgery , would , therefore , contraindicate study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Laparoscopic Cholecystectomy Surgery , Acute Pain , Perioperative Pain</keyword>
</DOC>